CLOV vs PSA
Clover Health Investments Corp (CLOV) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
PSA (PSA) common stock.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CLOV currently screens at market cap $1.55B. PSA currently screens at market cap $0.
Not investment advice. Open the CLOV and PSA stock pages for the full models.
Not investment advice.